相关实验视频
Updated: Sep 10, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
在人体心肌细胞中调节多克索鲁比辛的基因表达
J G Faber1, M van Herwijnen1, D Hauser1
1Maastricht University, Department of Translational Genomics, Research Institute for Oncology and Reproduction, Maastricht, Netherlands.
Toxicology
|August 25, 2025
概括
在 doxorubicin 治疗后,心脏细胞发生FOXO3核转移. 由于FOXO3的减少增加了对多克索鲁比的敏感性,这表明它在化疗中起着心脏保护作用.
科学领域:
- 心脏病学
- 分子生物学
- 药理学
背景情况:
- 多克索鲁比辛 (DOX) 是一种有效的化疗药物,但会引起心脏毒性.
- 人环素诱导的心脏毒性 (AIC) 限制了DOX的临床使用.
- FOXO3是参与心肌细胞应激反应的转录因子.
研究的目的:
- 研究FOXO3在心肌细胞转录调节中的作用.
- 确定FOXO3对多克索鲁比辛诱导的应激反应的影响.
- 探索FOXO3在对DOX进行心脏保护方面的潜力.
主要方法:
- 由DOX处理的人类心肌细胞 (hCM) 生成的RNA测序数据.
- 在FOXO3贫和对照HCM之间比较基因表达.
- 通过免疫光评估FOXO3核转位,并通过RT-qPCR验证基因变化.
主要成果:
- 在hCM中诱导FOXO3核转位.
- 在基线和DOX暴露后,FOXO3耗尽改变了心肌细胞基因表达.
- 在DNA修复,氧化应激和亡中发现了失调的基因.
结论:
- FOXO3 在心肌细胞对多克索鲁比的反应中起作用.
- 减少FOXO3会增加对多克索鲁比辛的敏感性.
- FOXO3可能是预防环素引起的心脏毒性的标.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Cardiomyopathy IV: Restrictive Cardiomyopathy
28
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28

